Smith & Nephew (Smith & Nephew) Short Percentage of Float

View and export this data going back to 1999. Start your Free Trial

What is Smith & Nephew Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Smith & Nephew's Short Percentage of Float

For the Medical Devices subindustry, Smith & Nephew's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smith & Nephew's Short Percentage of Float Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Short Percentage of Float falls into.

Smith & Nephew (Smith & Nephew) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » Short Percentage of Float

Comparable Companies

Traded in Other Exchanges

SNNUF:USA SNl:UK SN.:UK NPW1:Germany NPWA:Germany NPW1:Germany S1NN34:Brazil

Address

Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE

Website

https://www.smith-nephew.com

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.